BIB vs ENOR
Comparison between PROSHARES ULTRA NASDAQ BIOTECHNOLOGY (BIB, ETF) and ISHARES MSCI NORWAY ETF (ENOR, ETF).
5-Year PerformanceENOR has outperformed BIB, delivering a return of +9.2% compared to +0.2%
BIB vs ENOR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
Winner
BIB
$84M
ENOR
$84M
Expense Ratio
BIB
N/A
ENOR
0.53%
Max Drawdown
BIB
67.24%
Winner
ENOR
62.59%
Sharpe Ratio
Winner
BIB
1.76
ENOR
1.35
5Y Beta
BIB
1.50
Winner
ENOR
0.66
P/E Ratio
BIB
-42.32
ENOR
N/A
5Y Dividends CAGR
BIB
N/A
ENOR
19.10%
Debt to Equity
BIB
67.65%
ENOR
N/A
P/S Ratio
BIB
7.10
ENOR
N/A
P/B Ratio
BIB
5.24
ENOR
N/A
BIB vs ENOR - Holdings Comparison
BIB and ENOR have 1 common holdings. Overlap is -0.13%
BIB's top 25 holdings weight is 75.10%. ENOR's top 25 holdings weight is 84.18%.
| Rank | BIB | ENOR |
|---|---|---|
| #1 | NASDAQ BIOTECHNOLOGY INDEX SWAP (n/a) - 21.23% | EQUINOR ASA (n/a) - 11.80% |
| #2 | CASH (n/a) - 9.46% | DNB BANK ASA (n/a) - 11.51% |
| #3 | PROSHARES GENIUS MONEY MARKET ETF (IQMM) - 5.98% | KONGSBERG GRUPPEN ASA (n/a) - 5.58% |
| #4 | VERTEX PHARMACEUTICALS INC (VRTX) - 4.57% | NORSK HYDRO ASA (n/a) - 5.47% |
| #5 | AMGEN INC (AMGN) - 4.41% | AKER BP ASA (n/a) - 4.90% |
| #6 | NASDAQ BIO INDEX SWAP (n/a) - 3.97% | TELENOR ASA (n/a) - 4.33% |
| #7 | GILEAD SCIENCES INC (GILD) - 3.85% | MOWI ASA (n/a) - 3.92% |
| #8 | CTE PROSHARES TRUST M (n/a) - 3.34% | ORKLA ASA (n/a) - 3.67% |
| #9 | REGENERON PHARMACEUTICALS INC (REGN) - 2.52% | STOREBRAND ASA (n/a) - 3.63% |
| #10 | ALNYLAM PHARMACEUTICALS INC (ALNY) - 1.58% | YARA INTERNATIONAL ASA (n/a) - 3.57% |
| #11 | REVOLUTION MEDICINES INC ORDINARY SHARES (RVMD) - 1.56% | SUBSEA 7 SA (n/a) - 3.52% |
| #12 | BIOGEN INC (BIIB) - 1.21% | GJENSIDIGE FORSIKRING ASA (n/a) - 2.70% |
| #13 | MODERNA INC (MRNA) - 1.13% | FRONTLINE PLC (FRO) - 2.61% |
| #14 | ILLUMINA INC (ILMN) - 1.09% | SPAREBANK 1 SOR NORGE ASA (n/a) - 2.00% |
| #15 | ROIVANT SCIENCES LTD ORDINARY SHARES (ROIV) - 0.99% | VAR ENERGI ASA (n/a) - 1.97% |
| #16 | ARGENX SE ADR (ARGX) - 0.98% | VEND MARKETPLACES ASA ORDINARY SHARES (n/a) - 1.92% |
| #17 | ROYALTY PHARMA PLC CLASS A (RPRX) - 0.97% | SALMAR ASA (n/a) - 1.54% |
| #18 | UNITED THERAPEUTICS CORP (UTHR) - 0.91% | NORDIC SEMICONDUCTOR ASA (n/a) - 1.41% |
| #19 | INSMED INC (INSM) - 0.91% | AKER ASA CLASS A (n/a) - 1.36% |
| #20 | GUARDANT HEALTH INC (GH) - 0.89% | TGS ASA (n/a) - 1.26% |
| #21 | INCYTE CORP (INCY) - 0.89% | PROTECTOR FORSIKRING ASA (n/a) - 1.20% |
| #22 | VIATRIS INC (VTRS) - 0.74% | SPAREBANK 1 SMN DEPOSITORY RECEIPTS (n/a) - 1.13% |
| #23 | NEUROCRINE BIOSCIENCES INC (NBIX) - 0.66% | KONGSBERG MARITIME ASA (n/a) - 1.12% |
| #24 | ASCENDIS PHARMA AS (ASND) - 0.65% | BAKKAFROST P/F (n/a) - 1.03% |
| #25 | MEDPACE HOLDINGS INC (MEDP) - 0.61% | TOMRA SYSTEMS ASA (n/a) - 1.03% |
| Total Holdings | 258 | 65 |
BIB vs ENOR - Historical Returns
Returns include dividend reinvestment.
1M
BIB
+6.04%
Winner
ENOR
+7.52%
3M
Winner
BIB
+18.35%
ENOR
-2.21%
6M
BIB
+14.19%
Winner
ENOR
+16.39%
1Y
Winner
BIB
+86.91%
ENOR
+30.06%
5Y(CAGR)
BIB
+0.19%
Winner
ENOR
+9.22%
10Y(CAGR)
BIB
+8.01%
Winner
ENOR
+9.56%
Max(CAGR)
Winner
BIB
+17.28%
ENOR
+5.73%
BIB vs ENOR - Annual Returns (2010 - 2026)
Returns include dividend reinvestment.
| Year | BIB | ENOR |
|---|---|---|
| 2026 | +22.92% | +22.30% |
| 2025 | +57.12% | +30.35% |
| 2024 | -13.29% | -0.30% |
| 2023 | +0.43% | +8.03% |
| 2022 | -29.88% | -13.40% |
| 2021 | -4.77% | +18.51% |
| 2020 | +41.55% | +1.24% |
| 2019 | +43.60% | +12.25% |
| 2018 | -28.47% | -9.35% |
| 2017 | +35.43% | +20.83% |
| 2016 | -40.15% | +19.07% |
| 2015 | +11.86% | -15.90% |
| 2014 | +66.93% | -20.31% |
| 2013 | +144.02% | +7.44% |
| 2012 | +64.72% | +17.29% |
| 2011 | +13.41% | N/A |
| 2010 | +0.29% | N/A |
BIB vs ENOR Drawdown Comparison
The maximum drawdown for BIB was -67.24%, occurring on Jun 27, 2016. Recovery took 1389 trading sessions.
The maximum drawdown for ENOR was -55.31%, occurring on Mar 18, 2020. Recovery took 1726 trading sessions.
The current BIB drawdown is -10.89%. The current ENOR drawdown is -5.80%.
| Rank | BIB | ENOR |
|---|---|---|
| #1 | -67.24% Jul 20, 2015 - Jan 25, 2021 | -55.31% Jun 6, 2014 - Apr 15, 2021 |
| #2 | -66.19% Feb 8, 2021 - Jul 7, 2026 | -32.61% Mar 30, 2022 - May 21, 2025 |
| #3 | -40.88% May 12, 2011 - Jan 18, 2012 | -24.65% Mar 20, 2012 - Jan 2, 2013 |
| #4 | -39.01% Feb 25, 2014 - Sep 24, 2014 | -14.48% May 21, 2026 - Jun 26, 2026 |
| #5 | -36.30% Apr 15, 2010 - Dec 17, 2010 | -13.96% Feb 1, 2013 - Sep 18, 2013 |
| #6 | -24.73% Oct 5, 2012 - Mar 1, 2013 | -13.29% Oct 20, 2021 - Mar 30, 2022 |
| #7 | -20.33% May 14, 2013 - Jul 11, 2013 | -9.93% Jun 7, 2021 - Oct 13, 2021 |
| #8 | -17.74% Mar 20, 2015 - Jun 18, 2015 | -9.13% Oct 25, 2013 - Mar 5, 2014 |
| #9 | -17.57% Oct 1, 2013 - Nov 22, 2013 | -9.01% Sep 16, 2025 - Jan 2, 2026 |
| #10 | -16.83% Sep 24, 2014 - Oct 23, 2014 | -7.29% Feb 28, 2012 - Mar 20, 2012 |
| #11 | -13.85% Dec 19, 2014 - Jan 20, 2015 | -6.49% Sep 18, 2013 - Oct 18, 2013 |
| #12 | -13.72% Aug 2, 2013 - Sep 5, 2013 | -5.50% Mar 19, 2026 - Mar 31, 2026 |
| #13 | -13.27% Jan 22, 2014 - Feb 11, 2014 | -5.48% Jun 13, 2025 - Aug 22, 2025 |
| #14 | -13.06% Dec 9, 2014 - Dec 19, 2014 | -5.32% Apr 29, 2021 - Jun 1, 2021 |
| #15 | -11.91% Jul 7, 2026 - Jul 20, 2026 | -5.00% Mar 6, 2014 - Apr 24, 2014 |
Correlation
Correlation between BIB and ENOR is 0.41 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.41
-101
Dividend Comparison (2010 - 2026)
BIB vs ENOR dividend yield comparison.
| Year | BIB | ENOR |
|---|---|---|
| 2026 | 0.01% | 4.55% |
| 2025 | 0.77% | 2.96% |
| 2024 | 1.69% | 6.32% |
| 2023 | 0.07% | 5.06% |
| 2022 | 0.03% | 4.02% |
| 2021 | 0.00% | 2.24% |
| 2020 | 0.00% | 2.39% |
| 2019 | 0.00% | 3.15% |
| 2018 | 0.00% | 2.79% |
| 2017 | 0.00% | 2.47% |
| 2016 | 0.00% | 2.96% |
| 2015 | 0.00% | 3.24% |
| 2014 | 0.00% | 4.52% |
| 2013 | 0.00% | 2.65% |
| 2012 | 0.00% | 2.66% |
| 2010 | 0.15% | 0.00% |
Select Stocks to Compare
Popular: BIB vs SPYENOR vs SPY
More Comparisons
Compare with similar stocks